Skip to main content
Year archive

Dermapharm Holding SE — 2021 filings

All 28 regulatory filings released by Dermapharm Holding SE (DMP) in 2021, sourced directly from the official regulator.

28 Filings
2021 Period
2021 filings (28)
Filing Released Lang
Dermapharm Holding SE raises EBITDA forecast for the full year 2021
Earnings Release FY 2021
2021-12-16 English
Dermapharm Holding SE raises EBITDA forecast for the full year 2021
Regulatory Filings
2021-12-16 English
Dermapharm Holding SE acquires C3-Group and expands its activities in the cannabis market
M&A Activity
2021-12-15 English
Dermapharm Holding SE: Acquisition of C3 Cannabinoid Compound Company GmbH
M&A Activity
2021-12-15 English
Dermapharm Holding SE: strong EBITDA growth in Q3 2021
Earnings Release 9M 2021
2021-11-16 English
Q3 statement / Q3 financial report 2021
Interim / Quarterly Report 9M 2021
2021-11-16 English
Report Publication Announcement 2021
Report Publication Announcement
2021-11-09 English
Dermapharm Holding SE publishes H1 2021 report, confirms outlook for 2021 overall
Earnings Release H1 2021
2021-09-07 English
Half-yearly financial report 2021
Interim / Quarterly Report H2 2021
2021-09-07 German
Report Publication Announcement 2021
Report Publication Announcement
2021-08-31 English
Dermapharm Holding SE: Adjusted EBITDA up almost 50% in H1 2021
Earnings Release H1 2021
2021-08-24 English
DGAP-DD: Dermapharm Holding SE english
Director's Dealing
2021-07-22 English
Dermapharm Holding SE acquires equity investment in CORAT Therapeutics GmbH
M&A Activity
2021-07-07 English
Dermapharm Holding SE acquires equity investment in CORAT Therapeutics GmbH
M&A Activity
2021-07-07 English
Dermapharm Holding SE: Annual General Meeting approves dividend distribution of EUR 0.88 per share
AGM Information
2021-06-23 English
Dermapharm Holding SE: accelerated EBITDA growth in Q1 2021
Earnings Release Q1 2021
2021-05-18 English
Q1 statement / Q1 financial report 2021
Interim / Quarterly Report Q1 2021
2021-05-18 German
Dermapharm Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2021 in Grunwald mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2021-05-17 German
Report Publication Announcement 2021
Report Publication Announcement
2021-05-11 English
Dermapharm Holding SE: Federal Minister of Health Jens Spahn joins opening ceremony for vaccine manufacturing facility at subsidiary Allergopharma GmbH & Co. KG
Regulatory Filings
2021-04-30 English
Annual financial report 2020
Annual Report FY 2020
2021-04-15 English
Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures
Earnings Release FY 2020
2021-04-13 English
Report Publication Announcement 2021
Report Publication Announcement
2021-04-06 English
Dermapharm posts growth despite COVID-19 pandemic - consolidated revenue and EBITDA continue to rise
Earnings Release FY 2020
2021-03-30 English
Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million in sales in 2021
Regulatory Filings
2021-02-12 English
Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million contribution to sales in 2021
Earnings Release FY 2021
2021-02-12 English
DGAP-DD: Dermapharm Holding SE english
Director's Dealing
2021-02-02 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
Annual Report FY 2019
2021-01-14 German